Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Isis Pharmaceuticals to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases
-
AstraZeneca PLC H1 2015 results
-
AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa
-
AstraZeneca provides update on selumetinib in uveal melanoma
-
AstraZeneca completes agreement with Tillotts Pharma for Entocort
-
AstraZeneca enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan
-
IRESSA approved by US FDA for first-line treatment of patients with advanced EGFR mutation-positive non-small cell lung cancer
-
AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for Entocort
-
AstraZeneca and the University of Cambridge announce new joint PhD and clinical research scholarships
-
AstraZeneca to collaborate with Inserm in Type 2 Diabetes and Chronic Kidney Disease studies
Latest articles and press releases
All of our latest press releases and articles are available to explore
